Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Life Science

• Publication date

  2006-07-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.LFS.2006.01.039PMID 16513140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via P13K/AKT, ERK, and pertussis toxin-sensitive pathways

  2007cited by this paper
• p75NTR--live or let die.

  2005cited by this paper
• Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.

  2005cited by this paper
• Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain.

  2005cited by this paper
• Olanzapine and quetiapine protect PC12 cells from β‐amyloid peptide25–35‐induced oxidative stress and the ensuing apoptosis

  2005cited by this paper
• Olanzapine Attenuates the Okadaic Acid-Induced Spatial Memory Impairment and Hippocampal Cell Death in Rats

  2005cited by this paper
• Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine

  2004cited by this paper
• The dependence receptor hypothesis

  2004cited by this paper
• The p75 neurotrophin receptor: multiple interactors and numerous functions.

  2004cited by this paper
• Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.

  2004cited by this paper
• Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol.

  2004cited by this paper
• Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.

  2004cited by this paper
• Neurotrophins and their receptors: A convergence point for many signalling pathways

  2003cited by this paper
• Recent advances in the neurobiology of schizophrenia.

  2003cited by this paper
• Trk receptors: roles in neuronal signal transduction.

  2003cited by this paper
• Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

  2003cited by this paper
• Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide

  2003cited by this paper
• Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR).

  2003cited by this paper
• Atypical antipsychotics attenuate neurotoxicity of β‐amyloid(25–35) by modulating Bax and Bcl‐Xl/s expression and localization

  2003cited by this paper
• The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+‐induced apoptosis

  2003cited by this paper
• Expression of brain‐derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

  2003cited by this paper
• Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome.

  2003cited by this paper
• Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration.

  2002cited by this paper
• Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients.

  2002cited by this paper
• Neurotrophin signaling through the p75 neurotrophin receptor.

  2002cited by this paper
• Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal

  2002cited by this paper
• Schizophrenia as a disorder of neurodevelopment.

  2002cited by this paper
• Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine.

  2001cited by this paper
• Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

  2001cited by this paper
• Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

  2000cited by this paper
• Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.

  1999cited by this paper
• Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study.

  1999cited by this paper
• Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor

  1999cited by this paper
• New atypical antipsychotic medications.

  1998cited by this paper
• Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?

  1997cited by this paper
• Neurocognitive Impairment in Schizophrenia and how it Affects Treatment Options

  1997cited by this paper
• p75NTR and apoptosis: Trk-dependent and Trk-independent effects.

  1997cited by this paper
• New pharmacotherapeutic modalities for negative symptoms in psychosis

  1995cited by this paper
• Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.

  1995cited by this paper
• The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy

  1994cited by this paper
• Recent advances in the pharmacotherapy of schxzophrenia

  1994cited by this paper
• Defining treatment refractoriness in schizophrenia.

  1990cited by this paper
• At Issue: Defining Treatment Refractoriness in Schizophrenia

  1990cited by this paper
• Implications of normal brain development for the pathogenesis of schizophrenia.

  1987cited by this paper
• Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

  1982cited by this paper

• Transporters involved in adult rat cortical astrocyte dopamine uptake: Kinetics, expression and pharmacological modulation

  2023cites this paper
• Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach

  2019cites this paper
• The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia.

  2017cites this paper
• Clozapine blockade of MK-801-induced learning/memory impairment in the mEPM: Role of 5-HT1A receptors and hippocampal BDNF levels.

  2017cites this paper
• Bipolar disorder: Microrna profiling and genetics comparison with schizophrenia in a Malaysian population / Lim Chor Hong

  2016cites this paper
• Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatment

  2016cites this paper
• Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats

  2008influential citation
• Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cells.

  2007cites this paper
• Evidence for neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia.

  2007cites this paper